本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

SPYRE THERAPEUTICS INC

24.36
+0.86003.66%
盘后24.670.3100+1.27%19:47 EST
成交量:72.32万
成交额:1,764.87万
市值:18.90亿
市盈率:-12.16
高:25.02
开:23.47
低:23.03
收:23.50
52周最高:31.35
52周最低:10.91
股本:7,759.21万
流通股本:6,382.98万
量比:1.38
换手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-2.0036
每股收益(LYR):-3.1802
净资产收益率:-38.08%
总资产收益率:-30.20%
市净率:6.32
市盈率(LYR):-7.66

数据加载中...

2024/11/18

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/18

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/15

重要事件披露

Form 8-K - Current report
2024/10/01

SEC问询函

Form CORRESP - Correspondence
2024/09/14

SEC问询函

Form CORRESP - Correspondence
2024/08/08

重要事件披露

Form 8-K/A - Current report: [Amend]